European journal of ophthalmology · 2021
Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Németh János, Tapasztó Beáta, Aclimandos Wagih A, Kestelyn Philippe, Jonas Jost B, De Faber Jan-Tjeerd H N, Januleviciene Ingrida, Grzybowski Andrzej, Nagy Zoltán Zsolt, Pärssinen Olavi, Guggenheim Jeremy A, Allen Peter M, Baraas Rigmor C, Saunders Kathryn J, Flitcroft Daniel Ian, Gray Lyle S, Polling Jan Roelof, Haarman Annechien Eg, Tideman J Willem L, Wolffsohn James Stuart, Wahl Siegfried, Mulder Jeroen A, Smirnova Irina Yurievna, Formenti Marino, Radhakrishnan Hema, Resnikoff Serge
Аннотация
The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.